A lack of high quality and comprehensive information on how to treat and care for monkeypox may be preventing clinicians from responding to the current global outbreak according to a new study.
The monkeypox vaccine is being filled by a pharmacy.
According to a framework used to evaluate health guidance, most of the clinical management guidelines that were identified were of low quality.
Only five of the guidelines gave advice for children, and only three gave guidance for pregnant women or people with HIV.
Researchers found that the information on monkeypox treatments was not consistent.
The lack of robust guidance may cause confusion for clinicians treating monkeypox, especially those with no previous experience, and may negatively impact patient care, according to the study.
A total of 11,890. Since the current global outbreak of the disease began in May, the US has confirmed every case of monkeypox and orthopox in every state. More than 30,000 cases have been confirmed in 85 countries.
Monkeypox can be spread through close contact and can cause a wide range of symptoms. The current outbreak is small in scope and endemic to certain parts of Africa. The lack of comprehensive data on real-world use of monkeypox vaccine and treatments is a result of this. The current global outbreak of monkeypox may cause symptoms that are different from previous ones, which could result in undetected cases. According to the CDC, the FDA has not approved any treatments for monkeypox, but certain antivirals, such as Tpoxx, which are used for smallpox, may be recommended for treatment. These treatments are difficult to get. A public health emergency was declared by the Biden administration in order to speed up the distribution of vaccine. The FDA issued an emergency use authorization last week that will allow the Jynneos monkeypox vaccine to be given in smaller doses in order to quintuple the number of doses available in the country.
Several states, including New York and California, have seen a rise in the number of Jynneos monkeypox cases. The New York Times reported this week that the vaccine roll out continues to be hampered by the federal government's use of a new agency under the Department of Health and Human Services to distribute the shots. Local health officials told the Times that the decision has made it difficult to track and receive vaccine shipments.
There are new challenges for vaccine rollout because of a new monkeypox dosing strategy.
The White House declared a public health emergency due to vaccine struggles.
All Rights Reserved © 2024
